Literature DB >> 18425333

Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.

Guiqin Sun1, Jun Zhou, Ailan Yin, Yanqing Ding, Mei Zhong.   

Abstract

Zinc-finger protein 217 (ZNF217), a candidate oncogene on 20q13.2, can lead cultured human ovarian and mammary epithelial cells to immortalization, which indicates selective expression of ZNF217 affecting 20q13 amplification during critical early stages of cancer progression. In this study, we tested the hypothesis that ZNF217 is a key factor in regulating ovarian cancer proliferation and progression. We examined the effect of the inhibition of ZNF217 expression on proliferation and invasion by establishing the ZNF217 knockdown ovarian cancer cell line using RNA interference (RNAi). Our results showed that silencing of ZNF217 resulted in the effective inhibition of ovarian cancer cell growth and invasive ability. The results suggested that ZNF217 might play a crucial role in the proliferation and invasion of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425333

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Silencing of ZNF139-siRNA induces apoptosis in human gastric cancer cell line BGC823.

Authors:  Liqiao Fan; Bibo Tan; Yong Li; Qun Zhao; Yü Liu; Dong Wang; Zhidong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest.

Authors:  S P Angus; J R Nevins
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

3.  ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells.

Authors:  Aurélie Thollet; Julie A Vendrell; Léa Payen; Sandra E Ghayad; Sabrina Ben Larbi; Evelyne Grisard; Colin Collins; Marie Villedieu; Pascale A Cohen
Journal:  Mol Cancer       Date:  2010-11-08       Impact factor: 27.401

4.  Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells.

Authors:  Yong Li; Bi-bo Tan; Qun Zhao; Li-qiao Fan; Yü Liu; Dong Wang
Journal:  Mol Biol Rep       Date:  2014-02-11       Impact factor: 2.316

5.  GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.

Authors:  Ying Zhou; Ying Wei; Jing Zhu; Qingyuan Wang; Liang Bao; Yang Ma; Yu Chen; Dingqing Feng; Aijin Zhang; Jie Sun; Shreeram C Nallar; Keng Shen; Dhananjaya V Kalvakolanu; Weihua Xiao; Bin Ling
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

6.  MiR-203 suppresses ZNF217 upregulation in colorectal cancer and its oncogenicity.

Authors:  Zewu Li; Lutao Du; Zhaogang Dong; Yongmei Yang; Xin Zhang; Lili Wang; Juan Li; Guixi Zheng; Ailin Qu; Chuanxin Wang
Journal:  PLoS One       Date:  2015-01-26       Impact factor: 3.240

Review 7.  The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.

Authors:  Pascale A Cohen; Caterina F Donini; Nhan T Nguyen; Hubert Lincet; Julie A Vendrell
Journal:  Oncotarget       Date:  2015-12-08

8.  Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.

Authors:  Xingkang Jiang; Changwen Zhang; Shiyong Qi; Shanqi Guo; Yue Chen; E Du; Hongtuan Zhang; Xiaoming Wang; Ranlu Liu; Baomin Qiao; Kuo Yang; Zhihong Zhang; Yong Xu
Journal:  Oncotarget       Date:  2016-12-20

9.  ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer.

Authors:  Tian Hua; Rui-Min Wang; Xiao-Chong Zhang; Bei-Bei Zhao; Shao-Bei Fan; Deng-Xiang Liu; Wei Wang
Journal:  Biosci Rep       Date:  2021-12-22       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.